UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



FORM 6-K


REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a‑16 OR 15d‑16

OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE MONTH OF JULY 2019


COMMISSION FILE NUMBER 001-38976 

Genmab A/S
(Exact name of Registrant as specified in its charter)

Kalvebod Brygge 43

1560 Copenhagen V

Denmark

+45 70 20 27 28
(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports under cover Form 20‑F or Form 40‑F.

Form 20‑F       Form 40‑F 

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(1)

Yes       No     

Indicate by check mark if the registrant is submitting the Form 6‑K in paper as permitted by Regulation S‑T Rule 101(b)(7)

Yes       No     

This report on Form 6-K shall be deemed to be  incorporated by reference  in Genmab A/S’s registration statements on Form S-8 (File No. 333-232693) and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

GENMAB A/S

 

 

 

 

BY:

/s/ Birgitte Stephensen

 

 

Name: Birgitte Stephensen

 

 

Title: Senior Vice President, IPR & Legal

 

DATE: July 22, 2019   

EXHIBIT INDEX

 

 

 

Exhibit

Description of Exhibit

 

 

3.1

Articles of Association

99.1

Company Announcement Dated July 22, 2019

 

 

 

 

Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Genmab A S (PK) Charts.
Genmab A S (PK) (USOTC:GNMSF)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Genmab A S (PK) Charts.